Reynolds Monica L, Oliverio Andrea L, Zee Jarcy, Hendren Elizabeth M, O'Shaughnessy Michelle M, Ayoub Isabelle, Almaani Salem, Vasylyeva Tetyana L, Twombley Katherine E, Wadhwani Shikha, Steinke Julia M, Rizk Dana V, Waldman Meryl, Helmuth Margaret E, Avila-Casado Carmen, Alachkar Nada, Nester Carla M, Derebail Vimal K, Hladunewich Michelle A, Mariani Laura H
Division of Nephrology and Hypertension, University of North Carolina Kidney Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Department of Internal Medicine, Division of Nephrology, University of Michigan, Ann Arbor, Michigan, USA.
Kidney Int Rep. 2023 Feb 1;8(4):805-817. doi: 10.1016/j.ekir.2023.01.036. eCollection 2023 Apr.
Preeclampsia increases the risk for future chronic kidney disease (CKD). Among those diagnosed with CKD, it is unclear whether a prior history of preeclampsia, or other complications in pregnancy, negatively impact kidney disease progression. In this longitudinal analysis, we assessed kidney disease progression among women with glomerular disease with and without a history of a complicated pregnancy.
Adult women enrolled in the Cure Glomerulonephropathy study (CureGN) were classified based on a history of a complicated pregnancy (defined by presence of worsening kidney function, proteinuria, or blood pressure; or a diagnosis of preeclampsia, eclampsia, or hemolysis, elevated liver enzymes, and low platelets [HELLP] syndrome), pregnancy without these complications, or no pregnancy history at CureGN enrollment. Linear mixed models were used to assess estimated glomerular filtration rate (eGFR) trajectories and urine protein-to-creatinine ratios (UPCRs) from enrollment.
Over a median follow-up period of 36 months, the adjusted decline in eGFR was greater in women with a history of a complicated pregnancy compared to those with uncomplicated or no pregnancies (-1.96 [-2.67, -1.26] vs. -0.80 [-1.19, -0.42] and -0.64 [-1.17, -0.11] ml/min per 1.73 m per year, = 0.007). Proteinuria did not differ significantly over time. Among those with a complicated pregnancy history, eGFR slope did not differ by timing of first complicated pregnancy relative to glomerular disease diagnosis.
A history of complicated pregnancy was associated with greater eGFR decline in the years following glomerulonephropathy (GN) diagnosis. A detailed obstetric history may inform counseling regarding disease progression in women with glomerular disease. Continued research is necessary to better understand pathophysiologic mechanisms by which complicated pregnancies contribute to glomerular disease progression.
子痫前期会增加未来患慢性肾脏病(CKD)的风险。在那些被诊断为CKD的患者中,尚不清楚子痫前期病史或其他妊娠并发症是否会对肾脏疾病进展产生负面影响。在这项纵向分析中,我们评估了有或无复杂妊娠史的肾小球疾病女性的肾脏疾病进展情况。
参加肾小球肾炎治愈研究(CureGN)的成年女性根据复杂妊娠史(定义为肾功能恶化、蛋白尿或血压升高;或诊断为子痫前期、子痫或溶血、肝酶升高和血小板减少[HELLP]综合征)、无这些并发症的妊娠或在CureGN入组时无妊娠史进行分类。使用线性混合模型评估入组时的估计肾小球滤过率(eGFR)轨迹和尿蛋白与肌酐比值(UPCR)。
在中位随访期36个月内,有复杂妊娠史的女性与无复杂妊娠或无妊娠的女性相比,调整后的eGFR下降幅度更大(分别为每年每1.73平方米-1.96[-2.67,-1.26] vs. -0.80[-1.19,-0.42]和-0.64[-1.17,-0.11]ml/min,P = 0.007)。蛋白尿随时间无显著差异。在有复杂妊娠史的患者中,首次复杂妊娠时间相对于肾小球疾病诊断的时间对eGFR斜率无影响。
复杂妊娠史与肾小球肾炎(GN)诊断后数年更大的eGFR下降相关。详细的产科病史可能有助于为肾小球疾病女性的疾病进展咨询提供参考。有必要继续开展研究,以更好地了解复杂妊娠导致肾小球疾病进展的病理生理机制。